Edition:
United Kingdom

Grifols SA (GRLSbn.MC)

GRLSbn.MC on Madrid SE C.A.T.S.

19.56EUR
22 Jun 2018
Change (% chg)

-- (--)
Prev Close
€19.56
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
77,106
52-wk High
€21.30
52-wk Low
€16.36

Latest Key Developments (Source: Significant Developments)

Grifols To Pay Gross Dividend Of 0.204 Euro per Share
Friday, 25 May 2018 

May 25 (Reuters) - Grifols SA ::TO PAY GROSS DIVIDEND OF 0.204 EUR PER SHARE AGAINST FY 2017.  Full Article

Grifols says FDA approves genetic test and EMA biological sealant
Friday, 17 Nov 2017 

Nov 17 (Reuters) - GRIFOLS SA ::GETS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR ITS NEW GENETIC TEST TO DETECT ALPHA-1 ANTITRYPSIN DEFICIENCY‍​.THE EUROPEAN MEDICINES AGENCY (EMA) APPROVES NEW PRODUCT, BIOLOGICAL SEALANT, TO USE IN SURGICAL OPERATIONS IN ADULTS.‍​.  Full Article

Grifols gets approval from US FDA for new product
Monday, 6 Nov 2017 

Nov 6 (Reuters) - GRIFOLS SA ::EARNS APPROVAL FROM US FOOD AND DRUG ADMINISTRATION (FDA) FOR NEW PRODUCT FIBRIN SEALANT (HUMAN) COMPOSED OF TWO PLASMA PROTEINS AND INDICATED FOR SURGICAL USE IN ADULTS.‍​.  Full Article

Grifols 9-month net profit up 6.3 pct at 431.8 mln euros YoY
Thursday, 2 Nov 2017 

Nov 2 (Reuters) - GRIFOLS SA ::9-MONTH NET PROFIT 431.8 MILLION EUROS VERSUS 406.1 MILLION EUROS YEAR AGO.9-MONTH NET SALES 3.25 BILLION EUROS VERSUS 2.95 BILLION EUROS YEAR AGO.9-MONTH EBITDA 960.9 MILLION EUROS VERSUS 842.9 MILLION EUROS YEAR AGO.  Full Article

Grifols approves interim dividend of 0.18 eur/shr
Monday, 30 Oct 2017 

Oct 30 (Reuters) - GRIFOLS SA ::APPROVES INTERIM DIVIDEND OF 0.18 EURO PER SHARE PAYABLE DECEMBER 5‍​.  Full Article

Grifols says US prosecutor will not pursue case against Grifols
Friday, 7 Oct 2016 

Grifols SA :Says United States Department of Justice closes investigation on possible violations in Foreign Corrupt Practices Act against Grifols with declination to prosecute.  Full Article

Grifols' phase I Alzheimer vaccine study shows good safety profile, tolerability
Monday, 1 Aug 2016 

Grifols SA : Says unit Araclon Biotech presents phase I Alzheimer vaccine results showing good safety profile and tolerability . Says blind phase I study does not evaluate the effectiveness of treatment Further company coverage: [GRLS.MC] (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;)).  Full Article

Grifols reports H1 EBITDA at 553.6 mln euros
Thursday, 28 Jul 2016 

Grifols : H1 net profit 264.4 million euros ($293.1 million) versus 256 million euros in Reuters poll . H1 EBITDA 553.6 million euros versus 564 million euros in reuters poll .H1 net sales 1.95 billion euros versus 1.90 billion euros year ago.  Full Article

Grifols to buy a 48,000 square meter plot of land
Friday, 22 Jul 2016 

Grifols SA : To buy a plot of 48,716 square meters to expand its production facilities in Barcelona . Expects to start works on the new polygon in 2018 and complete them in 2019 Further company coverage: [GRLS.MC] (Gdynia Newsroom) ((gdynia.newsroom@thomsonreuters.com; +48 58 7720920;)).  Full Article

  • Previous
  • Next

Grifols SA News

Spanish stocks - Factors to watch on Friday

The following Spanish stocks may be affected by newspaper reports and other factors on Firday. Reuters has not verified the newspaper reports, and cannot vouch for their accuracy:

» More GRLSbn.MC News

Earnings vs. Estimates

» More Financials